Rewind Therapeutics Appoints Leading Neuroscience Drug Developer Ian J. Reynolds as Chief Executive Officer

LEUVEN, Belgium, October 3, 2018 -- (Healthcare Sales & Marketing Network) -- Rewind Therapeutics ("Rewind"), a private Belgian biotech company developing innovative first-in-class therapies for myelin-related diseases, announces the appointment... Biopharmaceuticals, Neurology, Personnel Rewind Therapeutics, myelin-related diseases
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news